Amended a previous report VIBHAVADI MEDICAL CENTER PUBLIC COMPANY LIMITED(VIBHA) PHIJIT WIRIYAMETTAKUL Reporter Warrant 2 09/03/2018 550,000 1.48 Buy VIBHAVADI MEDICAL CENTER PUBLIC COMPANY LIMITED(VIBHA
from 38% in FY20 to 34% and ROA slightly decreased from 9% in FY20 to 8%. Liquidity & Leverage: Current ratio was 0.39x, lower than previous year of 0.45x. AIS maintained strong financial position with
U City Public Company Limited (Registration No. 0107537000459) 21 TST Tower Soi Choei Phuang, Viphavadi-Rangsit Road, Chomphon, Chatuchak, Bangkok 10900, Thailand T: + 662 273 8838 F: + 662 273 8858 www.ucity.co.th Ref. No. U.SET 019/2017 October 30, 2017 Subject: Entire business transfer of Unicorn Enterprise Company Limited, capital increase, issuance of the U-W3 Warrants and U-W4 Warrants, issuance and offering of the newly issued preferred shares to be issued and offered to the existing shar...
Microsoft Word - 00. Project Unicorn - ELCLID of U - Revised Offering Price EN v2 (05122017) - clean.docx 1 (-Translation-) Ref. No. U.SET 024/2560 December 6, 2017 Subject: Notification on the Change of Details Concerning the Entire Business Transfer of Unicorn Enterprise Company Limited, Capital Increase, Issuance and Allocation of U-W3 and U-W4 Warrants, and Issuance and Offering of Newly Issued Preferred Shares to Specific Investors To: The President Stock Exchange of Thailand Enclosures: 1....
the corresponding period in the previous financial year shall also be provided. 13 2. The selected financial data presented shall include items generally corresponding to the following, except that the
experience, role and responsibility, year of working with the Company, competency, current and previous performance, also the potential and prospect that each employee will contribute to the company in the
-y) and 24.3% from the previous quarter (q-on-q), mainly from to 1) full contributions from the smooth operations of DT1&2, Phu Yen and Nam Che 1 which started commercial operation in June 2019, 2) 2.1
gains/losses from reported EBITDA. Inventory gains/losses in a period result from the movement in prices of raw mate- rials and products from the end of the previous reported period to the end of the
excluding inventory gains/losses from reported EBITDA. Inventory gains/losses in a period result from the movement in prices of raw mate- rials and products from the end of the previous reported period to the